Abrdn Life Sciences Investors (NYSE:HQL) is Rpo LLC’s 3rd Largest Position

Rpo LLC raised its position in shares of Abrdn Life Sciences Investors (NYSE:HQLFree Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 338,542 shares of the company’s stock after purchasing an additional 11,500 shares during the quarter. Abrdn Life Sciences Investors comprises about 6.7% of Rpo LLC’s investment portfolio, making the stock its 3rd biggest holding. Rpo LLC’s holdings in Abrdn Life Sciences Investors were worth $4,557,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in HQL. Kingsview Wealth Management LLC lifted its stake in shares of Abrdn Life Sciences Investors by 2.5% during the 4th quarter. Kingsview Wealth Management LLC now owns 36,937 shares of the company’s stock worth $497,000 after acquiring an additional 904 shares during the last quarter. Janney Montgomery Scott LLC lifted its stake in shares of Abrdn Life Sciences Investors by 1.7% during the 3rd quarter. Janney Montgomery Scott LLC now owns 72,249 shares of the company’s stock worth $901,000 after acquiring an additional 1,220 shares during the last quarter. Blue Bell Private Wealth Management LLC lifted its stake in shares of Abrdn Life Sciences Investors by 60.4% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 10,125 shares of the company’s stock worth $136,000 after acquiring an additional 3,811 shares during the last quarter. 180 Wealth Advisors LLC lifted its stake in shares of Abrdn Life Sciences Investors by 7.2% during the 4th quarter. 180 Wealth Advisors LLC now owns 122,995 shares of the company’s stock worth $1,689,000 after acquiring an additional 8,271 shares during the last quarter. Finally, Matisse Capital bought a new stake in shares of Abrdn Life Sciences Investors during the 4th quarter worth approximately $135,000. Hedge funds and other institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Price Performance

Shares of HQL stock traded down $0.12 on Wednesday, reaching $13.10. 11,383 shares of the company’s stock were exchanged, compared to its average volume of 103,133. Abrdn Life Sciences Investors has a 52 week low of $11.34 and a 52 week high of $14.37. The company’s fifty day simple moving average is $13.43 and its 200 day simple moving average is $13.37.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Thursday, May 23rd will be paid a dividend of $0.48 per share. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.39. This represents a $1.92 dividend on an annualized basis and a dividend yield of 14.66%. The ex-dividend date of this dividend is Wednesday, May 22nd.

Insider Buying and Selling

In other news, major shareholder Saba Capital Management, L.P. bought 2,022 shares of the firm’s stock in a transaction on Monday, April 22nd. The stock was acquired at an average cost of $12.88 per share, with a total value of $26,043.36. Following the transaction, the insider now directly owns 2,738,992 shares in the company, valued at approximately $35,278,216.96. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders acquired 383,459 shares of company stock valued at $5,091,312. Insiders own 10.06% of the company’s stock.

Abrdn Life Sciences Investors Profile

(Free Report)

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.

See Also

Want to see what other hedge funds are holding HQL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abrdn Life Sciences Investors (NYSE:HQLFree Report).

Institutional Ownership by Quarter for Abrdn Life Sciences Investors (NYSE:HQL)

Receive News & Ratings for Abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.